A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors

Stopped The trial was terminated for strategic reasons. The decision was not based on any safety and/or efficacy concerns.

Conditions

• Malignant Melanoma
• Melanoma
• Metastatic Melanoma
• Solid Tumors

Interventions

• DRUG: PF-08046031

Sponsor

Pfizer